Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation

Cancer Research

Volumn 59, Issue 19, 1999, Pages 4759-4760

  Afshari, Cynthia A ^a   Nuwaysir, Emile F ^a   Barrett, J Carl ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; COMPLEMENTARY DNA; ENVIRONMENTAL CHEMICAL; NEW DRUG; TUMOR MARKER;

CANCER RISK; CARCINOGEN TESTING; DRUG SAFETY; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION; GENE TECHNOLOGY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; TOXICITY TESTING;

CARCINOGENS; CONSUMER PRODUCT SAFETY; DNA, COMPLEMENTARY; GENE LIBRARY; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHARMACOLOGY, CLINICAL; TOXICOLOGY;

EID: 0033214657     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. Ames, B. N., and Gold, L. S. Environmental pollution, pesticides, and the prevention of cancer: misconceptions (published erratum appears in FASEB J., 11: 1330, 1997). FASEB J., 11: 1041-1052, 1997.
2. Schena, M., Shalon, D., Davis, R. W., and Brown, P. O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science (Washington DC), 270: 467-470, 1995.
3. Shalon, D., Smith, S. J., and Brown, P. O. A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genome Res., 6: 639-645, 1996.
4. Lipshutz, R. J., Fodor, S. P. A., Gingeras, T. R., and Lockhart, D. J. High density synthetic oligonucleotide arrays. Nat. Genet., 21 (Suppl.): 20-24, 1999.
5. Hacia, J. G. Resequencing and mutational analysis using oligonucleotide microarrays. Nat. Genet., 21 (Suppl.): 42-47, 1999.
6. Duggan, D. J., Bittner, M., Chen, Y., Meltzer, P., and Trent, J. M. Expression profiling using cDNA microarrays. Nat. Genet., 21 (Suppl.): 10-14, 1999.
7. Brown, P. O., and Botstein, D. Exploring the new world of the genome with DNA microarrays. Nat. Genet., 21 (Suppl.): 33-37, 1999.
8. Debouck C., and Goodfellow, P. N. DNA microarrays in drug discovery and development. Nat. Genet., 21 (Suppl.): 48-50, 1999.
9. Nuwaysir, E. F., Bittner, M., Trent, J., Barrett, J. C., and Afshari, C. A. Microarrays and toxicology: the advent of toxicogenomics. Mol. Carcinog., 24: 153-159, 1999.
10. Marton, M., DeRisi, J., Bennett, H., Iyer, V., Meyer, M., Roberts, C., Stoughton, R., Burchard, J., Slade, D., Dai, H., Bassett, D., Hartwell, L., Brown, P., and Friend, S. Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat. Med., 4: 1293-1301, 1998.
11. Wang, D. G., Fan, J. B., Siao, C. J., Berno, A., Young, P., Sapolsky, R., Ghandour, G., Perkins, N., Winchester, E., Spencer, J., Kruglyak, L., Stein, L., Hsie, L., Topaloglou, T., Hubbell, E., Robinson, E., Mittmann, M., Morris, M. S., Shen, N., Kilburn, D., Rioux, J., Nusbaum, C., Rozen, S., Hudson, T. J., Lipshutz, R., Chee, M., and Lander, E. S. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science (Washington DC), 280: 1077-1082, 1998.